Transfusion therapy

Results: 89



#Item
31Transfusion in Sickle Cell Disease: A Systematic Review of Benefits, Complications, and Management of Complications, 2012

Transfusion in Sickle Cell Disease: A Systematic Review of Benefits, Complications, and Management of Complications, 2012

Add to Reading List

Source URL: www.nhlbi.nih.gov

Language: English - Date: 2014-11-10 12:58:22
32Advanced Therapy Medicinal Products: how to bring cell-based medicinal products successfully to the market Workshop Programme 11 September 2014 Maritim Internationales Congress Centrum, Dresden, GERMANY

Advanced Therapy Medicinal Products: how to bring cell-based medicinal products successfully to the market Workshop Programme 11 September 2014 Maritim Internationales Congress Centrum, Dresden, GERMANY

Add to Reading List

Source URL: www.dgti-kongress.de

Language: English - Date: 2014-06-23 02:50:18
33Evidence-Based Management of Sickle Cell Disease: Expert Panel, 2014

Evidence-Based Management of Sickle Cell Disease: Expert Panel, 2014

Add to Reading List

Source URL: www.nhlbi.nih.gov

Language: English - Date: 2014-11-10 12:57:49
34The Management of Sickle Cell Disease Complications: A Systematic Review, 2012

The Management of Sickle Cell Disease Complications: A Systematic Review, 2012

Add to Reading List

Source URL: www.nhlbi.nih.gov

Language: English - Date: 2014-11-10 12:58:07
35Hypertransfusion Therapy in Sickle Cell Disease in Nigeria

Hypertransfusion Therapy in Sickle Cell Disease in Nigeria

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
36ITACCS  Summer 2005 BLOOD TRANSFUSIONS Nonetheless, deleterious effects of transfusion therapy have been

ITACCS Summer 2005 BLOOD TRANSFUSIONS Nonetheless, deleterious effects of transfusion therapy have been

Add to Reading List

Source URL: www.itaccs.com

Language: English - Date: 2011-10-07 16:03:45
37Automated selection of CD34+ cells for cellular therapy David Stroncek M.D. Chief, Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA  Abs

Automated selection of CD34+ cells for cellular therapy David Stroncek M.D. Chief, Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA Abs

Add to Reading List

Source URL: cellgenetherapy2014.conferenceseries.net

Language: English - Date: 2014-08-20 13:49:13
38Serious and Other Selected Adverse Events Reported for Human Gene Transfer Protocols Recombinant DNA Advisory Commitee Meeting March 2010

Serious and Other Selected Adverse Events Reported for Human Gene Transfer Protocols Recombinant DNA Advisory Commitee Meeting March 2010

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-09 14:56:01
39A Toolkit for the Introduction of a New Blood Product Prepared by  Ontario Regional Blood Coordinating Network

A Toolkit for the Introduction of a New Blood Product Prepared by Ontario Regional Blood Coordinating Network

Add to Reading List

Source URL: www.transfusionontario.org

Language: English - Date: 2014-09-10 13:07:51
40Transfusion independence with HMGA2 activation after lentiviral gene therapy of human β-thalassemia (UPDATE)  RAC - Bethesda, MD - December[removed]P. Leboulch

Transfusion independence with HMGA2 activation after lentiviral gene therapy of human β-thalassemia (UPDATE) RAC - Bethesda, MD - December[removed]P. Leboulch

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2014-01-08 12:15:00